Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul-Aug;39(4):e70150.
doi: 10.1111/jvim.70150.

Identification of a Novel Mutation in the SERPINE1 Gene Causing Clinical Hyperfibrinolysis in English Springer Spaniel Dogs

Affiliations

Identification of a Novel Mutation in the SERPINE1 Gene Causing Clinical Hyperfibrinolysis in English Springer Spaniel Dogs

Kelley Kilpatrick et al. J Vet Intern Med. 2025 Jul-Aug.

Abstract

Background: A 7-month-old female spayed English Springer Spaniel (ESS) was evaluated for spontaneous hemoperitoneum. Hyperfibrinolysis was identified on thromboelastography.

Hypothesis/objectives: To identify a genetic mutation causing congenital hyperfibrinolysis in the proband and evaluate the prevalence of the mutation in the ESS breed.

Animals: Client-owned ESS with hemorrhage and a non-affected littermate. Samples of DNA from 3 ESS, 1 Welsh Springer Spaniel (WSS) with unexplained hemorrhage, and 199 ESS with no history of hemorrhage.

Methods: Whole genome sequencing (WGS) of the proband with variant filtering against an in-house WGS database of 671 presumably unaffected dogs identified a deleterious variant of SERPINE1 unique to the proband, which encodes for plasminogen activator inhibitor 1 (PAI-1). SERPINE1 was genotyped in the remaining animal population by Sanger sequencing or a Taqman assay. Liquid chromatography tandem mass spectrometry (LC-MS/MS) was performed on platelet pellets from the proband, a littermate, and three unrelated healthy ESS.

Results: Whole genome sequencing of the proband identified a unique homozygous insertion at chr6:8640592 in exon 1 of SERPINE1, which is predicted to cause a premature stop codon. The unaffected littermate was heterozygous for the mutation. Two unrelated ESS and 1 WSS with post-operative hemorrhage were homozygous for the mutation. Absence of PAI-1 in the proband's platelets was documented using LC-MS/MS.

Conclusions and clinical importance: This novel mutation in SERPINE1 is associated with the absence of the PAI-1 protein in platelets and might cause hemorrhage because of hyperfibrinolysis in ESS and related breeds.

Keywords: coagulation; delayed postoperative hemorrhage; plasminogen activator inhibitor‐1; whole genome sequencing.

PubMed Disclaimer

Conflict of interest statement

Steven G. Friedenberg serves as Associate Editor for the Journal of Veterinary Internal Medicine. He was not involved in the review of this manuscript. The other authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Sanger sequencing chromatograms surrounding the reported insertion in exon 1 of the SERPINE1 gene at position chr6:8640592 (gray box) for the proband, her littermate, and three English Springer Spaniels (ESS) and one Welsh Springer Spaniel (WSS) from the Cornell University Veterinary Biobank with a history of unexplained hemorrhage. A homozygous insertion is present in the proband and three of the four dogs from Cornell. The proband's littermate is heterozygous for the same insertion, and one of the four dogs from Cornell (ESS 3) is homozygous for the reference allele.

Similar articles

References

    1. Birkbeck R., Humm K., and Cortellini S., “A Review of Hyperfibrinolysis in Cats and Dogs,” Journal of Small Animal Practice 60 (2019): 641–655. - PubMed
    1. Gils A. and Declerck P. J., “Plasminogen Activator Inhibitor‐1,” Current Medicinal Chemistry 11 (2004): 2323–2334. - PubMed
    1. Zoia A., Drigo M., Caldin M., Simioni P., and Piek C. J., “Fibrinolysis in Dogs With Intracavitary Effusion: A Review,” Animals 12 (2022): 2487. - PMC - PubMed
    1. Fay W. P., Shapiro A. D., Shih J. L., Schleef R. R., and Ginsburg D., “Complete Deficiency of Plasminogen‐Activator Inhibitor Type 1 due to a Frameshift Mutation,” New England Journal of Medicine 327 (1992): 1729–1733. - PubMed
    1. Iwaki T., Tanaka A., Miyawaki Y., et al., “Life‐Threatening Hemorrhage and Prolonged Wound Healing Are Remarkable Phenotypes Manifested by Complete Plasminogen Activator Inhibitor‐1 Deficiency in Humans,” Journal of Thrombosis and Haemostasis 9, no. 6 (2011): 1200–1206, 10.1111/j.1538-7836.2011.04288.x. - DOI - PubMed

Substances

LinkOut - more resources